Cargando…
The current and future state of companion diagnostics
Companion diagnostics are an indispensable part of personalized medicine and will likely continue to rapidly increase in number and application to disease areas. The first companion diagnostics were launched in the 1980s and in the face of significant initial skepticism from drug developers as to wh...
Autores principales: | Agarwal, Amit, Ressler, Dan, Snyder, Glenn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397716/ https://www.ncbi.nlm.nih.gov/pubmed/25897259 http://dx.doi.org/10.2147/PGPM.S49493 |
Ejemplares similares
-
Companion Diagnostics: State of the Art and New
Regulations
por: Valla, Vasiliki, et al.
Publicado: (2021) -
Targeted therapies with companion diagnostics in the management of breast cancer: current perspectives
por: Myers, Meagan B
Publicado: (2016) -
The current landscape of the FDA approved companion diagnostics
por: Jørgensen, Jan Trøst
Publicado: (2021) -
Necessity of strengthening the current clinical regulatory for companion diagnostics: An institutional comparison of the FDA, EMA, and MFDS
por: Kang, Su Lim, et al.
Publicado: (2023) -
Multiplexed Prostate Cancer Companion Diagnostic Devices
por: Aidoo-Brown, Josephine, et al.
Publicado: (2021)